You stole my heart but that's ok, I have three more at home in the freezer!

Friday, September 20, 2013

Pharmacology - Glutamatergics in treating depression, anxiety, addiction (New Frontier of Research)

There is a great body of evidence supporting the use of glutamatergics as adjuncts to monoaminergic drugs or alone. These include NMDA antagonists for depression, AMPA agonists for depression, neurodegenerative disease, and many others. mGlu antagonists (metabotropic glutamate receptors, not the already widely-targeted ionotropic glutamate receptors) hold particular promise, although the N2B recep

via Drugs Forum